767 results on '"Sabate, Manel"'
Search Results
202. VENTRICULAR ARRHYTHMIAS AND CLINICAL OUTCOMES IN PATIENTS WITH LEFT MAIN DISEASE TREATED WITH PCI OR CABG: THE EXCEL TRIAL
203. COMPARISON OF TRANSFEMORAL VERSUS TRANSRADIAL SECONDARY ACCESS IN TRANSCATHETER AORTIC VALVE REPLACEMENT
204. Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration
205. Mitral Valve Gradient after Percutaneous Repair with the Mitraclip System: Evolution over Time
206. 2.3 Exosomes Derived From Endothelial Progenitor Cells Modulate Flow-Induced Remodeling and Increase Vasculogeneis in Mesenteric Arteries of Mice
207. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
208. Cost-Effectiveness of Drug-Eluting Stents in Elderly Patients With Coronary Artery Disease: The SENIOR Trial
209. The use of Impella LP 2.5 Assist Device in the Percutaneous Coronary Intervention of the Unprotected Left Main Coronary Artery Disease: Feasibilty and Safety in a Single Center Experience: C-044
210. Emergent vs Elective Percutaneous Coronary Intervention in Left Main Coronary Artery Disease: Long-Term Results from a Single Center Registry: C-038
211. Lack of association between the P2Y 12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease
212. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting
213. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis: Angiographic and intravascular ultrasound findings of a randomized study
214. Transcatheter mitral valve repair in nonagenarians.
215. Crossing the Boundaries of Treatment of Valvular Heart Disease in Patients With Liver Cirrhosis
216. Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysis
217. Guidance of intracoronary radiation therapy based on dose-volume histograms derived from quantitative intravascular ultrasound
218. Sirolimus-Eluting Stents vs Brachytherapy for Restenosis
219. Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease
220. Intracoronary Brachytherapy After Stenting De Novo Lesions in Diabetic Patients: Results of a Randomized Intravascular Ultrasound Study
221. Coronary stenting versus balloon angioplasty in small vessels: A meta-analysis from 11 randomized studies
222. Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction
223. Predictors of Mortality Following Rescue Percutaneous Intervention
224. Factores predictores de mortalidad en la angioplastia de rescate
225. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
226. The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
227. 12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry
228. Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX
229. Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction.
230. Comments on the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation
231. Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First 400 Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry
232. Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents
233. TCT-483 Influence of Multivessel Disease and Impact of Complete Revascularization in Left Ventricular Function Recovery Following STEMI
234. TCT-256 Minimally Invasive Transradial Approach for Percutaneous Closure of Aortic Paravalvular Leaks: A Single-Center Experience
235. TCT-421 Predicting 2 Years All-Cause Mortality After Contemporary PCI: Revising and Updating the Logistic Clinical SYNTAX Score in the GLOBAL LEADERS Study
236. TCT-306 Association Between Prediabetes and Clinical Outcomes After Left Main Coronary Artery Revascularization by PCI or CABG: Analysis From the EXCEL Trial
237. TCT-111 Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for Three Vessel Disease
238. TCT-642 PARIS Risk Score Stratified Analysis of Clinical Outcomes Among Elderly Patients (Aged > 75 Years) Treated With 23-Month Ticagrelor Monotherapy Following 1-Month DAPT After PCI in the GLOBAL LEADERS Trial
239. Spontaneous coronary artery dissection: Not so infrequent to be ignored
240. Abstract 600: Anti-Angiogenic Effects of Circulating Exosomes From Patients With Acute Coronary Syndrome: Potential Role of miR-199a and miR-125a
241. Minimally-invasive Transesophageal Echocardiography for Left Atrial Appendage Occlusion With a Latest-generation Microprobe. Initial Experience
242. Initial Experience of Patient Selection for Mitraclip-XTR in a Single Center
243. LONG-TERM TICAGRELOR MONOTHERAPY IN ELDERLY PATIENTS UNDERGOING PCI IN THE GLOBAL LEADERS STUDY
244. Impact of post‐procedural minimal stent area on 2‐year clinical outcomes in the SYNTAX II trial
245. Multivessel spontaneous coronary artery dissection involving the left main coronary artery: a case report
246. Early dysfunction and long-term improvement in endothelium-dependent vasodilation in the infarct-related artery after thrombolysis
247. Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: Results of the randomized investigation by the thoraxcenter of antisense dna using local delivery and ivus after coronary stenting (ITALICS) trial
248. Two‐year outcomes after percutaneous coronary intervention with drug‐eluting stents or bare‐metal stents in elderly patients with coronary artery disease.
249. Antiplatelet and Anticoagulant Therapy after Coronary-Artery Stenting
250. Estado actual de la braquiterapia intracoronaria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.